| NCT ID | NCT03990909 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Portland VA Medical Center |
| Condition | Sleep Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2019-03-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2019-03-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experimental period.
Eligibility Criteria
Inclusion Criteria: * Veteran * English Speaking * Accessible via phone * Sleep problems Exclusion Criteria: * Decisional impairment * Nickel allergy * Maple syrup urine disease or family history of disease * Allergy to sucralose * Currently taking BCAAs
Contact & Investigator
Miranda M Lim, MD, PhD
PRINCIPAL INVESTIGATOR
Portland VA Medical Center
Frequently Asked Questions
Who can join the NCT03990909 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Sleep Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03990909 currently recruiting?
Yes, NCT03990909 is actively recruiting participants. Contact the research team at lmir@ohsu.edu for enrollment information.
Where is the NCT03990909 trial being conducted?
This trial is being conducted at Portland, United States.
Who is sponsoring the NCT03990909 clinical trial?
NCT03990909 is sponsored by Portland VA Medical Center. The principal investigator is Miranda M Lim, MD, PhD at Portland VA Medical Center. The trial plans to enroll 300 participants.